AVALIDE - 55154-2023-8 - (IRBESARTAN AND HYDROCHLOROTHIAZIDE)

Alphabetical Index


Drug Information of AVALIDE

Product NDC: 55154-2023
Proprietary Name: AVALIDE
Non Proprietary Name: IRBESARTAN AND HYDROCHLOROTHIAZIDE
Active Ingredient(s): 12.5; 150    mg/1; mg/1 & nbsp;   IRBESARTAN AND HYDROCHLOROTHIAZIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of AVALIDE

Product NDC: 55154-2023
Labeler Name: Cardinal Health
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020758
Marketing Category: NDA
Start Marketing Date: 19970930

Package Information of AVALIDE

Package NDC: 55154-2023-8
Package Description: 2430 TABLET in 1 BOTTLE, PLASTIC (55154-2023-8)

NDC Information of AVALIDE

NDC Code 55154-2023-8
Proprietary Name AVALIDE
Package Description 2430 TABLET in 1 BOTTLE, PLASTIC (55154-2023-8)
Product NDC 55154-2023
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name IRBESARTAN AND HYDROCHLOROTHIAZIDE
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19970930
Marketing Category Name NDA
Labeler Name Cardinal Health
Substance Name HYDROCHLOROTHIAZIDE; IRBESARTAN
Strength Number 12.5; 150
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of AVALIDE


General Information